argenx SE (ARGNF)
OTCMKTS · Delayed Price · Currency is USD
786.05
-47.45 (-5.69%)
At close: Oct 30, 2025
argenx SE Market Cap
argenx SE has a market cap or net worth of $49.81 billion as of October 31, 2025. Its market cap has increased by 47.83% in one year.
Market Cap
49.81B
Enterprise Value
45.99B
Revenue
3.68B
Ranking
n/a
PE Ratio
32.48
Stock Price
$786.05
Market Cap Chart
Since July 10, 2014, argenx SE's market cap has increased from 166.50M to 49.81B, an increase of 29,813.53%. That is a compound annual growth rate of 65.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 31, 2025 | 49.81B | 32.82% |
| Dec 31, 2024 | 37.50B | 67.18% |
| Dec 29, 2023 | 22.43B | 8.92% |
| Dec 30, 2022 | 20.59B | 11.15% |
| Dec 31, 2021 | 18.53B | 32.86% |
| Dec 31, 2020 | 13.95B | 102.37% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 655.38M |
| Glass House Brands | 563.30M |
| Northwest Biotherapeutics | 366.55M |
| Silence Therapeutics | 345.28M |
| Nika Pharmaceuticals | 312.10M |
| CytoDyn | 302.34M |
| American Oncology Network | 297.14M |